Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Genetic risk and retinopathy of prematurity: homing in on a target?

The Original Article was published on 12 February 2024

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bhatnagar, A., Skrehot, H. C., Bhatt, A., Herce, H. & Weng, C. Y. Epidemiology of Retinopathy of Prematurity in the US From 2003 to 2019. JAMA Ophthalmol. 141, 479–485 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Rysavy, M. A. et al. An Immature Science: Intensive Care for Infants Born at </=23 Weeks of Gestation. J. Pediatr. 233, 16–25.e11 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dammann, O. & Stansfield, B. K. Neonatal sepsis as a cause of retinopathy of prematurity: An etiological explanation. Prog. Retin Eye Res. 98, 101230 (2024).

    Article  PubMed  Google Scholar 

  4. Swan, R. et al. The genetics of retinopathy of prematurity: a model for neovascular retinal disease. Ophthalmol. Retin. 2, 949–962 (2018).

    Article  Google Scholar 

  5. Gimenez, L. G. et al. Genetic susceptibility for retinopathy of prematurity and its associated comorbidities. Pediatr Res. (2024)

  6. Li, X. et al. Genome-wide association identifies novel ROP risk loci in a multiethnic cohort. Commun. Biol. 7, 107 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ilguy, S. et al. The relationship of retinopathy of prematurity with brain-derivated neurotrophic factor, vascular endotelial growth factor-A, endothelial PAD domain protein 1 and nitric oxide synthase 3 gene polymorphisms. Ophthalmic Genet. 42, 725–731, (2021).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

A.M. and B.K.S. conceptualized the manuscript. A.M. wrote the first draft. All authors approved the final draft.

Corresponding author

Correspondence to Brian K. Stansfield.

Ethics declarations

Competing interests

The author received in-kind research funding from and is a member of the Speaker’s Bureau for Mead Johnson Nutrition. The authors report no conflicts of interest to disclose relevant to the current work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morsy, A., Stansfield, B.K. Genetic risk and retinopathy of prematurity: homing in on a target?. Pediatr Res (2024). https://doi.org/10.1038/s41390-024-03312-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41390-024-03312-2

Search

Quick links